Both local and circulatory SP-D levels are disturbed in smokers and COPD patients, who exhibit vast induction of serum SP-D with a concomitant reduction of BAL SP-D (9, 19). This evidence concerns the gene SFTPD and chronic obstructive pulmonary disease.